{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:28:27Z","timestamp":1793392107384,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007659","name":"Bayer Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajog.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:18:52Z","timestamp":1662700732000},"page":"873.e1-873.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-1224","authenticated-orcid":false,"given":"Jeffrey T.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Lukkari-Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesmean","family":"Wahdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Serrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.09.007_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.007_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aogs.14110","article-title":"Thirty years of Mirena: a story of innovation and change in women\u2019s healthcare","volume":"100","author":"Gemzell-Danielsson","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2022.09.007_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A\u00a0randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.09.007_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135309","article-title":"The effect of age, parity and body mass index on the efficacy, safety, placement and user satisfaction associated with two low-dose levonorgestrel intrauterine contraceptive systems: subgroup analyses of data from a Phase III trial","volume":"10","author":"Gemzell-Danielsson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2022.09.007_bib8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13625187.2018.1465546","article-title":"Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study","volume":"23","author":"Merki-Feld","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2022.09.007_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmjsrh-2020-200962","article-title":"More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years","volume":"47","author":"Gemzell-Danielsson","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.ajog.2022.09.007_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajog.2003.07.021","article-title":"Pregnancy during the use of levonorgestrel intrauterine system","volume":"190","author":"Backman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0010-7824(90)90046-X","article-title":"Long-term contraception with the levonorgestrel 20 mcg\/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study","volume":"42","author":"Sivin","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0010-7824(86)90080-6","article-title":"Five years\u2019 experience with levonorgestrel-releasing IUDs","volume":"33","author":"Luukkainen","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/AOG.0000000000003411","article-title":"Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG COMMITTEE OPINION, Number 785","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/03009734.2016.1208310","article-title":"Prevention of unintended pregnancy and use of contraception-important factors for preconception care","volume":"121","author":"Kallner","year":"2016","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.ajog.2022.09.007_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150120","article-title":"Economic benefits of investing in women\u2019s health: a systematic review","volume":"11","author":"Onarheim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2022.09.007_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1353\/eca.2013.0001","article-title":"Fifty years of family planning: new evidence on the long-run effects of increasing access to contraception","volume":"2013","author":"Bailey","year":"2013","journal-title":"Brookings Pap Econ Act"},{"key":"10.1016\/j.ajog.2022.09.007_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/07853899309164159","article-title":"A\u00a0Latin American experience with levonorgestrel IUD","volume":"25","author":"Fa\u00fandes","year":"1993","journal-title":"Ann Med"},{"key":"10.1016\/j.ajog.2022.09.007_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0010-7824(93)90089-P","article-title":"Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil","volume":"47","author":"D\u00edaz","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.contraception.2017.10.007","article-title":"Pregnancy outcomes associated with extended use of the 52-mg 20 \u03bcg\/day levonorgestrel-releasing intrauterine system beyond 60 months: a chart review of 776 women in Brazil","volume":"97","author":"Bahamondes","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.contraception.2019.10.010","article-title":"Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system","volume":"101","author":"Westhoff","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2013.11.011","article-title":"INTRA Writing Group. Worldwide use of intrauterine contraception: a review","volume":"89","author":"Buhling","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajog.2020.01.014","article-title":"Effectiveness and safety of extending intrauterine device duration: a systematic review","volume":"223","author":"Ti","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2022.09.007_bib31","first-page":"1","article-title":"Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: a health technology assessment","volume":"16","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.ajog.2022.09.007_bib32","article-title":"Progestogen-releasing intrauterine systems for heavy menstrual bleeding","volume":"6","author":"Bofill Rodriguez","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2022.09.007_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.11.1288","article-title":"Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding","volume":"222","author":"Chen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/ejc.8.2.87.92","article-title":"Recommendation for confidence interval and sample size calculation for the Pearl Index","volume":"8","author":"Gerlinger","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2022.09.007_bib35","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1097\/01.AOG.0000662940.54289.4d","article-title":"Contraceptive efficacy and safety of 52 mg LNG-IUS for up to eight years: Year 6 data from the Mirena Extension Trial [OP04-1D]","volume":"135","author":"Jensen","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(98)00029-8","article-title":"Perforations with intrauterine devices. Report from a Swedish survey","volume":"57","author":"Andersson","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/11585050-000000000-00000","article-title":"Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres","volume":"34","author":"van Grootheest","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2022.09.007_bib40","first-page":"547","article-title":"Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy","volume":"6","author":"Xu","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2022.09.007_bib41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","volume":"198","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jadohealth.2015.05.001","article-title":"Adolescent experiences with intrauterine devices: a qualitative study","volume":"57","author":"Schmidt","year":"2015","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.ajog.2022.09.007_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"Moreau","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2022.09.007_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/dep426","article-title":"Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)\u2013a multicentre prospective study","volume":"25","author":"Gemzell-Danielsson","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.09.007_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AOG.0000000000003034","article-title":"Five-year contraceptive efficacy and safety of a levonorgestrel 52-mg intrauterine system","volume":"133","author":"Teal","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232935","article-title":"Measurement in the study of menstrual health and hygiene: a systematic review and audit","volume":"15","author":"Hennegan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2022.09.007_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12905-020-0887-y","article-title":"Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review","volume":"20","author":"Magnay","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ajog.2022.09.007_bib49","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","volume":"4","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2022.09.007_bib50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/09513590802444167","article-title":"Levonorgestrel-releasing intrauterine system: why do some women dislike it?","volume":"24","author":"Daud","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2022.09.007_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12905-021-01210-x","article-title":"Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding","volume":"21","author":"Beelen","year":"2021","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ajog.2022.09.007_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.007_bib53","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0002-9378(11)90607-3","article-title":"Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices","volume":"166","author":"Sivin","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.007_bib54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0010-7824(92)90122-A","article-title":"Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T","volume":"46","author":"Andersson","year":"1992","journal-title":"Contraception"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822007293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822007293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:40:30Z","timestamp":1757590830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822007293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0002937822007293"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.09.007","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.05.022","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}